Analyst ratings, especially from major banks like Deutsche Bank, can significantly influence investor sentiment and stock prices. A Buy rating combined with a high price target suggests that the analyst sees strong fundamentals or potential in Karuna Therapeutics, which could lead to increased investor interest and a rise in the stock price in the short term.